Neovolta Financials
Neovolta (NEOV) reported $8.4M in revenue for fiscal year 2025, up 218.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Sales reacceleration improved overhead absorption, but cash burn still leaves this business dependent on external balance-sheet support.
Between FY2024 and FY2025, operating leverage improved as operating margin moved from-88.4% to-56.0% on a much larger sales base. But cash conversion worsened because receivables and inventory expanded with growth, leaving operating cash flow at-$4.4M and forcing financing inflows of$4.2M just to keep cash from shrinking faster.
FY2025 marks a balance-sheet shift from a nearly debt-light posture to a more liability-funded model: total liabilities reached
Gross margin remained modest at
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Neovolta's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Neovolta scores 24.49, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($196.6M) relative to total liabilities ($3.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Neovolta passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
Neovolta reported a net loss of $5.0M while operations used $4.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Neovolta reported an operating loss of $4.7M against $320K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Neovolta generated $8.4M in revenue in fiscal year 2025. This represents an increase of 218.6% from the prior year.
Neovolta reported -$5.0M in net income in fiscal year 2025. This represents a decrease of 118.6% from the prior year.
Neovolta earned -$0.15 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 114.3% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Neovolta held $795K in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Neovolta's gross margin was 17.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.4 percentage points from the prior year.
Neovolta's operating margin was -56.0% in fiscal year 2025, reflecting core business profitability. This is up 32.4 percentage points from the prior year.
Neovolta's net profit margin was -59.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 27.3 percentage points from the prior year.
Neovolta's ROE was -173.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 122.9 percentage points from the prior year.
Capital Allocation
Neovolta invested $157K in research and development in fiscal year 2025. This represents an increase of 721.3% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
NEOV Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|---|
| Revenue | $18.1M | $8.4M+218.6% | $2.6M-23.5% | $3.5M-22.7% | $4.5M-7.3% | $4.8M |
| Cost of Revenue | $14.2M | $6.9M+224.2% | $2.1M-22.9% | $2.8M-27.3% | $3.8M-8.8% | $4.2M |
| Gross Profit | $3.9M | $1.5M+195.2% | $510K-25.8% | $688K+3.1% | $667K+3.0% | $648K |
| R&D Expenses | $598K | $157K+721.3% | $19K-36.0% | $30K-56.3% | $69K+60.0% | $43K |
| SG&A Expenses | $12.4M | $6.1M+114.5% | $2.8M-14.1% | $3.3M-48.2% | $6.4M-23.0% | $8.3M |
| Operating Income | -$9.4M | -$4.7M-101.8% | -$2.3M+11.3% | -$2.6M+54.2% | -$5.8M+24.8% | -$7.7M |
| Interest Expense | $295K | $320K | $0-100.0% | $4K-91.7% | $50K+102.0% | $25K |
| Income Tax | N/A | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$11.5M | -$5.0M-118.6% | -$2.3M+12.7% | -$2.6M+54.5% | -$5.8M+24.1% | -$7.6M |
| EPS (Diluted) | — | -$0.15-114.3% | -$0.07+12.5% | -$0.08 | -$0.28+34.9% | -$0.43 |
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
NEOV Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Total Assets | $6.8M+46.1% | $4.7M-28.4% | $6.5M+57.7% | $4.1M+26.5% | $3.3M |
| Current Assets | $6.7M+43.1% | $4.7M-28.4% | $6.5M+57.7% | $4.1M+26.5% | $3.3M |
| Cash & Equivalents | $795K-19.4% | $986K-50.7% | $2.0M+506.2% | $330K-22.4% | $426K |
| Inventory | $2.1M+19.6% | $1.8M-30.7% | $2.6M+15.3% | $2.2M+34.7% | $1.7M |
| Accounts Receivable | $3.0M+65.2% | $1.8M-1.1% | $1.8M+38.6% | $1.3M+16.8% | $1.1M |
| Total Liabilities | $3.9M+6275.5% | $61K+54.7% | $39K-97.4% | $1.5M+1228.1% | $114K |
| Current Liabilities | $3.5M+5647.8% | $61K+54.7% | $39K-97.3% | $1.5M+1443.1% | $94K |
| Long-Term Debt | N/A | N/A | N/A | $1.1M | N/A |
| Total Equity | $2.9M-36.7% | $4.6M-28.9% | $6.5M+147.1% | $2.6M-16.9% | $3.1M |
| Retained Earnings | -$25.8M-24.3% | -$20.7M-12.5% | -$18.4M-16.7% | -$15.8M-57.4% | -$10.0M |
Not reported in any period shown, so not listed: Goodwill.
NEOV Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -$9.1M | -$4.4M-335.5% | -$1.0M+51.8% | -$2.1M-81.2% | -$1.2M-31.7% | -$884K |
| Financing Cash Flow | $22.8M | $4.2M | $0-100.0% | $3.8M+254.0% | $1.1M | $0 |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
NEOV Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 |
|---|---|---|---|---|---|
| Gross Margin | 17.9%-1.4pp | 19.3%-0.6pp | 19.9%+5.0pp | 14.9%+1.5pp | 13.4% |
| Operating Margin | -56.0%+32.4pp | -88.3%-12.1pp | -76.3% | -128.7% | -158.6% |
| Net Margin | -59.7%+27.3pp | -87.1%-10.7pp | -76.4% | -129.8% | -158.5% |
| Return on Equity | -173.0%-122.9pp | -50.1%-9.3pp | -40.8%+181.0pp | -221.8%+21.0pp | -242.8% |
| Return on Assets | -74.0%-24.5pp | -49.5%-8.9pp | -40.6%+100.1pp | -140.7%+93.7pp | -234.4% |
| Current Ratio | 1.90-74.3x | 76.21-88.5x | 164.74+161.9x | 2.84-31.8x | 34.61 |
| Debt-to-Equity | 1.34+1.3x | 0.010.0x | 0.01-0.4x | 0.43+0.4x | 0.04 |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Where Neovolta Ranks
Frequently Asked Questions
What is Neovolta's annual revenue?
Neovolta (NEOV) reported $8.4M in total revenue for fiscal year 2025. This represents a 218.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Neovolta's revenue growing?
Neovolta (NEOV) revenue grew by 218.6% year-over-year, from $2.6M to $8.4M in fiscal year 2025.
Is Neovolta profitable?
No, Neovolta (NEOV) reported a net income of -$5.0M in fiscal year 2025, with a net profit margin of -59.7%.
What is Neovolta's gross margin?
Neovolta (NEOV) had a gross margin of 17.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Neovolta's operating margin?
Neovolta (NEOV) had an operating margin of -56.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Neovolta's net profit margin?
Neovolta (NEOV) had a net profit margin of -59.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Neovolta's return on equity (ROE)?
Neovolta (NEOV) has a return on equity of -173.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Neovolta's operating cash flow?
Neovolta (NEOV) recorded an outflow of $4.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Neovolta's total assets?
Neovolta (NEOV) had $6.8M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Neovolta spend on research and development?
Neovolta (NEOV) invested $157K in research and development during fiscal year 2025.
What is Neovolta's current ratio?
Neovolta (NEOV) had a current ratio of 1.90 as of fiscal year 2025, which is generally considered healthy.
What is Neovolta's debt-to-equity ratio?
Neovolta (NEOV) had a debt-to-equity ratio of 1.34 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Neovolta's return on assets (ROA)?
Neovolta (NEOV) had a return on assets of -74.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Neovolta's cash runway?
Based on fiscal year 2025 data, Neovolta (NEOV) had $795K in cash against an annual operating cash burn of $4.4M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Neovolta's Altman Z-Score?
Neovolta (NEOV) has an Altman Z-Score of 24.49, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Neovolta's Piotroski F-Score?
Neovolta (NEOV) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Neovolta's earnings high quality?
Neovolta (NEOV) reported a net loss of $5.0M while operations used $4.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Neovolta cover its interest payments?
Neovolta (NEOV) reported an operating loss of $4.7M against $320K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Neovolta?
Neovolta (NEOV) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.